Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VPHM - Viropharma Inc -- Ignore unavailable to you. Want to Upgrade?

To: Cacaito who wrote (1464)	6/13/2003 3:10:13 PM
From: scaram(o)uche	Respond to of 2557

>> ..."subsequent"...aka ALIBI !!! << That's what I'm hoping. Obviously, FDA seemed to understand how the situation rolled around. You get human data in humans, and the length of the trial determined that this side effect was seen. I just don't get it. But that's why I've said that the shorts either have inside information of some sort (re. pre-existing data relating to enzyme induction and/or re. HVC-371 results to date), or they're really stupid. I don't have a feel for which it is. The leverage is pronounced. Makes no sense to me at all. Good to see you here again. You've called everything about this stock correctly.